Folke Per-Olof Wallström
Chairman at CAMURUS AB
Net worth: 5 M $ as of 29/04/2024
Folke Per-Olof Wallström active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CAMURUS AB | Chairman | 31/12/2014 | - |
| Independent Dir/Board Member | 31/12/2009 | - | |
| Arosia Communication AB | Director/Board Member | - | - |
| Founder | - | - | |
| Camurus Development AB | Chairman | - | - |
| Reabyran AB | Corporate Officer/Principal | - | - |
| Arosgruppen Fastigheter Fjärdingen AB | Chairman | - | - |
Career history of Folke Per-Olof Wallström
Former positions of Folke Per-Olof Wallström
| Companies | Position | Start | End |
|---|---|---|---|
| Q-LINEA AB | Director/Board Member | 31/12/2017 | 12/06/2023 |
| HANSA BIOPHARMA AB | Director/Board Member | 31/12/2010 | 28/05/2018 |
| Independent Dir/Board Member | 31/12/2010 | 28/05/2018 | |
Swedish Orphan International Holding AB
 Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | Director/Board Member | 31/12/2003 | 02/06/2010 |
| KARO PHARMA AB (PUBL) | Chief Executive Officer | - | 22/04/2010 |
| President | 31/03/2010 | 22/04/2010 | |
| ░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░ | - | - |
| ░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░ ░░░░░░░░░ ░░░░ ░ ░░░░░░░░░ ░░ | ░░░░░░░░ | - | - |
| ░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
| ░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░ | ░░░░░░░░ | - | - |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░ | ░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░ ░░░░░░ ░░ | ░░░░░░░░ | - | - |
| ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Folke Per-Olof Wallström
| University of Uppsala | Graduate Degree |
Statistics
International
| Sweden | 27 |
| United Kingdom | 3 |
| United States | 3 |
Operational
| Chairman | 11 |
| Director/Board Member | 7 |
| Corporate Officer/Principal | 7 |
Sectoral
| Health Technology | 14 |
| Finance | 3 |
| Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 6 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| KARO PHARMA AB (PUBL) | Health Technology |
| CAMURUS AB | Health Technology |
| HANSA BIOPHARMA AB | Health Technology |
| NEOS AB | Health Technology |
| Q-LINEA AB | Health Technology |
| Private companies | 23 |
|---|---|
Envirotainer AB
 Envirotainer AB Containers/PackagingProcess Industries Envirotainer AB provides cold chain solutions for the pharmaceutical supply chain. It offers active cold chain services, qualification services, shipment set up services, technical support, post-shipment analysis and telemetry solution. The company was founded in 1985 and is headquartered in Sollentuna, Sweden. | Process Industries |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | Health Technology |
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Health Technology |
| Pharmacia AB | Health Technology |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
| Karobio Usa | |
AROSGRUPPEN Holding AB
 AROSGRUPPEN Holding AB Real Estate DevelopmentFinance Arosgruppen Holding AB engages in the leasing out of real estate and trade of securities. It also offers consulting services with the field of architecture. The company was founded in 1988 and is headquartered in Uppsala, Sweden. | Finance |
Mediplast AB
 Mediplast AB Medical SpecialtiesHealth Technology Mediplast AB engages in the marketing and sale of medical equipment and medical disposable products. It offers products in the following areas such as operation; thoracic intervention, neurology, and orthopedics; radiology; neuroradiology and cardiology; bandages; anesthesia, otorhinolaryngology; ostomy; and Home healthcare. The company was founded in 1960 and is headquartered in Malmo, Sweden. | Health Technology |
| Aggal Invest AB | |
Melacure Therapeutics AB
 Melacure Therapeutics AB Pharmaceuticals: MajorHealth Technology Melacure Therapeutics AB develops and manufactures pharmaceutical products. Its products are used for treatment of obesity, irritable bowel syndrome, inflammation, and sexual dysfunction. The company was founded in 1998 and is located in Uppsala, Sweden. | Health Technology |
Patients Pending Ltd.
 Patients Pending Ltd. Hospital/Nursing ManagementHealth Services Patients Pending Ltd. provides a daily solution to people living with diabetes. Its products include Timesulin for Flexpen, Solostar, Kwikpen and FlexTouch. The firm sells its products online and through a network of independent distributors and pharmacies. The company was founded by John Sjolund, Marcel Botha and Andreas Sjolund in 2010 and is headquartered in London, the United Kingdom. | Health Services |
| Arosia Communication AB | |
| Arosgruppen Fastigheter Fjärdingen AB | |
| Mb Erikssons Bygg & Fastighet AB | |
| Reabyran AB | |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Health Technology |
Aros Arkitekter AB
 Aros Arkitekter AB Engineering & ConstructionIndustrial Services Part of Sweco AB, Aros Arkitekter AB is a Swedish company that provides architectural services. The company is based in Stockholm, Sweden. Aros Arkitekter was acquired by Sweco AB from Arosgruppen Holding AB on September 22, 2010. | Industrial Services |
| Chemilia AB | |
| Camurus Development AB | |
Nexttobe AB
 Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Finance |
| Masmastaren Fjardingen AB | |
| Addcode Design AB | |
| Patients Pending AB |
